Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase over the prior year.

Bourla’s total equity holdings, nearly 597,000 shares, are worth more than $32 million as of Thursday’s closing price $54.24.

He’s entitled to a golden parachute of nearly $113 million, which was valued at end of December 2021.